Company intelligence / Profile preview

Fluigent

Le Kremlin-Bicetre, Francefluigent.com ↗

Ownership: Private
Employees: ~54
Development stage: Commercial

Overview

Fluigent develops and commercializes advanced pressure-based fluid control systems for microfluidics. Their products are used globally by academic labs and industrial partners to enable precise manipulation of fluids at the microscale. The company’s innovations have accelerated research in cell biology, organ-on-a-chip models, drug discovery, diagnostics development, and more. They do not develop therapeutics or clinical candidates themselves but provide essential tools that underpin R&D across the life sciences.

Modalities: Device
Industry: Non-Drug Biotech

Partnerships

Not specifically listed; collaborates with academic labs and industrial clients globally.

Beyond the preview

Go deeper on Fluigent.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fluigent.

Explore the full profile